Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
ARWR [NASD]
Arrowhead Research Corp.
Index- P/E- EPS (ttm)-1.14 Insider Own1.00% Shs Outstand51.87M Perf Week2.97%
Market Cap593.39M Forward P/E- EPS next Y-0.45 Insider Trans- Shs Float51.39M Perf Month-19.38%
Income-44.30M PEG- EPS next Q-0.22 Inst Own77.30% Short Float10.68% Perf Quarter-9.42%
Sales0.20M P/S2966.96 EPS this Y31.60% Inst Trans-0.16% Short Ratio2.91 Perf Half Y-2.22%
Book/sh4.32 P/B2.65 EPS next Y52.10% ROA-47.50% Target Price28.10 Perf Year298.61%
Cash/sh3.10 P/C3.69 EPS next 5Y8.45% ROE-52.80% 52W Range2.77 - 27.63 Perf YTD5.44%
Dividend- P/FCF- EPS past 5Y28.30% ROI-82.60% 52W High-58.60% Beta2.81
Dividend %- Quick Ratio15.40 Sales past 5Y-25.40% Gross Margin- 52W Low313.00% ATR0.85
Employees54 Current Ratio15.40 Sales Q/Q- Oper. Margin- RSI (14)42.45 Volatility5.19% 6.50%
OptionableYes Debt/Eq0.01 EPS Q/Q24.40% Profit Margin- Rel Volume0.62 Prev Close11.66
ShortableYes LT Debt/Eq0.00 EarningsAug 04 Payout- Avg Volume1.89M Price11.44
Recom2.00 SMA20-8.43% SMA50-10.61% SMA200-11.27% Volume1,162,800 Change-1.89%
05-Mar-14Initiated RBC Capital Mkts Outperform $35
05-Mar-14Initiated Deutsche Bank Buy $45
26-Feb-13Initiated Dawson James Buy $4
24-Jul-14 01:59PM  Arrowhead Research (ARWR) Highlighted As Today's Perilous Reversal Stock at TheStreet
22-Jul-14 09:50AM  Tekmira Pharmaceuticals: Is The Clinical Hold Sell-Off A Buying Opportunity? at Seeking Alpha
10-Jul-14 09:46AM  Arrowhead Research (ARWR) Highlighted As Today's Perilous Reversal Stock at TheStreet
09-Jul-14 09:47AM  Trade-Ideas: Arrowhead Research (ARWR) Is Today's "Dead Cat Bounce" Stock at TheStreet +8.07%
05:00AM  'Fast Money' Recap: Waiting for the Dust to Settle at TheStreet
08-Jul-14 05:46PM  [video] Biotech buys right now at CNBC -8.06%
27-Jun-14 07:50AM  Biotechnology Equities Movers and Shakers -- Research on ZIOPHARM Oncology, Clovis Oncology, Arrowhead Research, and NPS Pharma PR Newswire
07:50AM  Biotechnology Equities Movers and Shakers -- Research on ZIOPHARM Oncology, Clovis Oncology, Arrowhead Research, and NPS Pharma
26-Jun-14 11:02AM  Trade-Ideas: Arrowhead Research (ARWR) Is Today's "Dead Cat Bounce" Stock at TheStreet +5.96%
11:02AM  Trade-Ideas: Arrowhead Research (ARWR) Is Today's "Dead Cat Bounce" Stock
25-Jun-14 08:45AM  Arrowhead (ARWR): Current Price Does Not Reflect Value Zacks Small Cap Research -5.43%
08:45AM  Arrowhead (ARWR): Current Price Does Not Reflect Value
24-Jun-14 01:04AM  Better Buy: Isis Pharmaceuticals vs. Arrowhead Research at Motley Fool -5.71%
01:04AM  Better Buy: Isis Pharmaceuticals vs. Arrowhead Research
23-Jun-14 09:52AM  Arrowhead Research (ARWR) Showing Signs Of Perilous Reversal Today at TheStreet
09:52AM  Arrowhead Research (ARWR) Showing Signs Of Perilous Reversal Today
19-Jun-14 04:42PM  Why Arrowhead Research Corp. Shares Swooned at Motley Fool -7.34%
04:42PM  Why Arrowhead Research Corp. Shares Swooned
11:59AM  Arrowhead Announces New Clinical Candidate ARC-AAT for Treatment of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease Business Wire
11:59AM  Arrowhead Announces New Clinical Candidate ARC-AAT for Treatment of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease
16-Jun-14 09:45AM  Today's Dead Cat Bounce Stock: Arrowhead Research (ARWR) at TheStreet +8.84%
09:45AM  Today's Dead Cat Bounce Stock: Arrowhead Research (ARWR)
07:30AM  Arrowhead Research Set to Join Russell 3000 Index Business Wire
07:30AM  Arrowhead Research Set to Join Russell 3000 Index
13-Jun-14 05:41PM  Arrowhead Issues a Statement on Intellectual Property Protection for ARC-520 Business Wire -9.74%
05:41PM  Arrowhead Issues a Statement on Intellectual Property Protection for ARC-520
11-Jun-14 04:05PM  Arrowhead to Host Analyst Day to Discuss New Rare Liver Disease Candidate Business Wire
04:05PM  Arrowhead to Host Analyst Day to Discuss New Rare Liver Disease Candidate
10-Jun-14 04:05PM  Arrowhead to Present at Upcoming Investor Conferences Business Wire
04:05PM  Arrowhead to Present at Upcoming Investor Conferences
29-May-14 07:30AM  Arrowhead to Present at the Jefferies 2014 Global Healthcare Conference Business Wire
07:30AM  Arrowhead to Present at the Jefferies 2014 Global Healthcare Conference
27-May-14 07:04PM  Biotech 101: RNA Drugs at Motley Fool +12.82%
14-May-14 01:04PM  ARROWHEAD RESEARCH CORP Financials EDGAR Online Financials
01:04PM  ARROWHEAD RESEARCH CORP Financials
12-May-14 09:45AM  Stock To Watch: Arrowhead Research (ARWR) In Perilous Reversal at TheStreet
09:45AM  Stock To Watch: Arrowhead Research (ARWR) In Perilous Reversal
07-May-14 12:38AM  Arrowhead Research's (ARWR) CEO Christopher Anzalone on Q2 2014 Results - Earnings Call Transcript at Seeking Alpha
06-May-14 04:25PM  Q2 2014 Arrowhead Research Corp Earnings Conference Call (ARWR) Q2 2014 Results - Earnings Call Webcast at Seeking Alpha -6.75%
04:08PM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E EDGAR Online
04:01PM  Arrowhead to Present at Upcoming Scientific Conferences Business Wire
04:01PM  Arrowhead Reports Fiscal 2014 Second Quarter Financial Results Business Wire
03:57PM  ARROWHEAD RESEARCH CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
07:07AM  Q2 2014 ARROWHEAD RESH CORP Earnings Release - After Market Close CCBN
01-May-14 07:30AM  Arrowhead to Present at Deutsche Bank 39th Annual Health Care Conference Business Wire
30-Apr-14 06:00PM  Five Small Biotech Stocks Analysts Think Will Triple at Forbes
29-Apr-14 04:05PM  Arrowhead to Report Fiscal 2014 Second Quarter Financial Results Business Wire
09:22AM  Tiger Soup at Seeking Alpha
16-Apr-14 09:47AM  Trade-Ideas: Arrowhead Research Corporation (ARWR) Is Today's "Dead Cat Bounce" Stock at TheStreet +8.49%
14-Apr-14 03:00PM  Why Arrowhead Research (ARWR) Stock is Down Today at TheStreet
02:42PM  Alnylam slips after Novartis reportedly cuts back RNAi development at theflyonthewall.com
07-Apr-14 10:15AM  Trade-Ideas: Arrowhead Research Corporation (ARWR) Is Today's "Dead Cat Bounce" Stock at TheStreet
01-Apr-14 01:37PM  Why Arrowhead Research Corp. Shares Jumped at Motley Fool +11.33%
11:24AM  Why Arrowhead Research (ARWR) Stock Is Up Today at TheStreet
07:31AM  Arrowhead completes enrollment of first cohort in phase 2a trial of ARC-520 at theflyonthewall.com
07:30AM  Arrowhead Completes Enrollment of First Cohort in Phase 2a Trial of Chronic Hepatitis B Candidate ARC-520 Business Wire
26-Mar-14 06:31PM  3 Biotechs Falling Like a Knife: Arrowhead, Celldex, Receptos at Motley Fool
24-Mar-14 12:07PM  On The Fly: Midday Wrap at theflyonthewall.com -16.09%
07:30AM  Arrowhead Begins Dosing in Phase 2a Trial of RNAi Therapeutic ARC-520 in Chronic Hepatitis B Patients Business Wire
21-Mar-14 06:03PM  Nasdaq stocks posting largest percentage decreases AP -13.06%
01:24PM  Nasdaq stocks posting largest percentage decreases AP
15-Mar-14 09:32AM  It's Official: Merck Now Owns Part of Alnylam at Motley Fool
14-Mar-14 01:21PM  Nasdaq stocks posting largest percentage decreases AP
13-Mar-14 06:05PM  Nasdaq stocks posting largest percentage decreases AP -8.35%
01:59PM  Nasdaq stocks posting largest percentage decreases AP
10-Mar-14 07:30AM  Arrowhead to Present at Barclays Global Healthcare Conference Business Wire +7.66%
07:30AM  Arrowhead to Present at Barclays Global Healthcare Conference
07-Mar-14 02:31PM  Arrowhead Research Surges as It Advances Its Drug for Hepatitis B into Phase 2 at Motley Fool
05-Mar-14 04:22PM  On The Fly: Closing Wrap at theflyonthewall.com +24.46%
02:49PM  3 Biotech Winners on Wednesday: Arrowhead, Osiris, Tekmira at Wall St. Cheat Sheet
02:49PM  3 Biotech Winners on Wednesday: Arrowhead, Osiris, Tekmira
02:31PM  Why Arrowhead Research (ARWR) His a Five-Year High Today at TheStreet
02:31PM  Why Arrowhead Research (ARWR) His a Five-Year High Today
12:41PM  On The Fly: Midday Wrap at theflyonthewall.com
12:02PM  Today's Top Performers In Health Care at TheStreet
12:02PM  Today's Top Performers In Health Care
11:50AM  Arrowhead Research: 'Early Innings' for 'Major Story' at Barrons.com
11:50AM  Arrowhead Research: 'Early Innings' for 'Major Story'
11:14AM  Arrowhead Surges As Analysts Laud Hepatitis B Drug Optionetics
11:14AM  Arrowhead Surges As Analysts Laud Hepatitis B Drug at Investor's Business Daily
11:14AM  Arrowhead Surges As Analysts Laud Hepatitis B Drug
06:17AM  Coverage initiated on Arrowhead Research by RBC Capital Mkts Briefing.com
06:17AM  Coverage initiated on Arrowhead Research by RBC Capital Mkts and Deutsche Bank Briefing.com
03-Mar-14 09:45AM  Arrowhead Research Corporation (ARWR) Marked As A Dead Cat Bounce Stock at TheStreet
09:45AM  Arrowhead Research Corporation (ARWR) Marked As A Dead Cat Bounce Stock
07:30AM  Arrowhead Receives Regulatory Approval to Begin Phase 2a Trial of Chronic Hepatitis B Candidate ARC-520 Business Wire
24-Feb-14 11:54AM  Use Options For A Chance To Buy ARWR At A 55% Discount at TheStreet
08:59AM  Arrowhead Closes Underwritten Offering with Gross Proceeds of $120 Million Business Wire
21-Feb-14 04:08PM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhi EDGAR Online
07:30AM  Arrowhead Listing Upgraded to NASDAQ Global Select Market Business Wire
20-Feb-14 04:01PM  Arrowhead to Present at RBC Capital Markets' Global Healthcare Conference Business Wire
19-Feb-14 09:14AM  Arrowhead: A Functional Cure For The Hepatitis B Virus at Seeking Alpha +11.29%
09:05AM  Arrowhead Announces Pricing of Underwritten Offering of Common Stock Business Wire
18-Feb-14 04:15PM  Arrowhead Research files to sell common stock, no amount given theflyonthewall.com
04:14PM  Arrowhead Announces Proposed Underwritten Offering of Common Stock Business Wire
12-Feb-14 04:09PM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhib EDGAR Online
08-Feb-14 01:04PM  ARROWHEAD RESEARCH CORP Financials EDGAR Online Financials
07-Feb-14 08:51AM  Arrowhead: There Is Still Plenty Of Room For Share Price Appreciation at Seeking Alpha +18.64%
07:31AM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vot EDGAR Online
06-Feb-14 11:59AM  Arrowhead Research Continues Its Surge After Analyst Upgrade at Wall St. Cheat Sheet
Arrowhead Research Corporation, a biopharmaceutical company, develops targeted RNAi therapeutics in the United States. The company's product candidate comprise ARC-520, an RNAi-based therapeutic that has completed a Phase 1 clinical trial for the treatment of chronic hepatitis B virus (HBV) infection; and Adipotide, which is in Phase I clinical trial for the treatment for obesity and related metabolic disorders. Its platform technologies include Dynamic Polyconjugate platform, a RNA delivery system that addresses multiple organ systems and cell types, promotes multi-log gene knockdown, and induces endosomal escape; and Homing Peptides platform, a library of short peptides. The company also develops DPC-enabled RNAi therapeutic, a pre-clinical stage product to treat an undisclosed orphan liver disease. It also has research collaboration and license agreement with Shire AG to develop and commercialize targeted peptide-drug conjugates. The company, formerly known as InterActive Group, Inc., was founded in 2003 and is headquartered in Pasadena, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
McKenney CharlesDirectorJun 09Option Exercise2.3922,00052,48039,220Jun 10 09:28 PM
McKenney CharlesDirectorJun 09Sale14.3222,000315,00517,220Jun 10 09:28 PM
Myszkowski Kenneth AllenCFOFeb 12Option Exercise2.0116,00032,16087,500Feb 12 07:15 PM
Myszkowski Kenneth AllenCFOFeb 12Sale18.7716,000300,29071,500Feb 12 07:15 PM
FRYKMAN EDWARD WDirectorFeb 07Option Exercise10.005,00050,00027,000Feb 10 07:45 PM
FRYKMAN EDWARD WDirectorFeb 07Sale15.983,14850,29623,852Feb 10 07:45 PM